The bradykinin B 2 receptor antagonist Icatibant (HOE 140) corrects avid Na + retention in rats with CCl 4 -induced liver cirrhosis: possible role of enhanced microvascular leakage

By Wirth K.J.   Bickel M.   Hropot M.   Gunzler V.   Heitsch H.   Ruppert D.   Scholkens B.A.  

European Journal of Pharmacology, Vol. 337, Iss. 1, 1997-10 ,pp. : 45-53

Elsevier

Access to resources Recommend Favorite

Pharmacological characterization of a novel, orally active, nonpeptide bradykinin B 2 receptor antagonist, FR167344

By Inamura N.   Asano M.   Hatori C.   Sawai H.   Jiro Hirosumi   Fujiwara T.   Kayakiri H.   Satoh S.   Abe Y.   Inoue T.   Sawada Y.   Oku T.   Nakahara K.  

European Journal of Pharmacology, Vol. 333, Iss. 1, 1997-08 ,pp. : 79-86

Elsevier

Access to resources Recommend Favorite

Antioedematogenic and antinociceptive actions of NPC 18521, a novel bradykinin B 2 receptor antagonist

By De Campos R.O.P.   Alves R.V.   Kyle D.J.   Chakravarty S.   Mavunkel B.J.   Calixto J.B.  

European Journal of Pharmacology, Vol. 316, Iss. 2, 1996-12 ,pp. : 277-286

Elsevier

Access to resources Recommend Favorite

Effect of the bradykinin B 2 receptor antagonist Hoe140 in experimental pneumococcal meningitis in the rat

By Lorenzl S.   Kodel U.   Frei K.   Pfister H.-W.  

European Journal of Pharmacology, Vol. 308, Iss. 3, 1996-07 ,pp. : 335-341

Elsevier

Access to resources Recommend Favorite

Effect of FK3657, a non-peptide bradykinin B 2 receptor antagonist, on allergic airway disease models

By Hirayama Y.   Miyayasu K.   Yamagami K.   Imai T.   Ohkubo Y.   Mutoh S.  

European Journal of Pharmacology, Vol. 467, Iss. 1, 2003-04 ,pp. : 197-203

Elsevier

Access to resources Recommend Favorite